Johnson & Johnson's press release — JNJ's reaction is being measured
JNJ's realized reaction is still being measured.
· PR Newswire · Press release · Realized reaction, point-in-time, zero look-ahead.
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
Via PR Newswire
Reaction is being measured.
This event is recent. News Quantified labels the realized price reaction once the trading sessions after the news complete — point-in-time, with zero look-ahead. The measured move will appear here, and below in JNJ’s reaction history.
Where this JNJ event came from, and what the tape did with it.
Johnson & Johnson issued a press release, carried via PR Newswire, on Oct 24, 2026. It was the only Johnson & Johnson headline News Quantified labeled that day.
Against the price at the news timestamp, JNJ's reaction is still being measured.
How this compares to JNJ’s usual reaction.
Across 2,000+ labeled events, JNJ’s median 30-minute reaction to all news is +0.06% (56% up); by the close it is +0.06%.
| Middle 50% of JNJ reactions | -0.26% to +0.39% |
|---|---|
| Median reaction (30-min) | +0.06% |
| Measured reactions | 2,000+ |
Half of all Johnson & Johnson news events land between -0.26% and +0.39% at 30 minutes; this one is a single draw from that distribution.
You just saw one reaction. There are 26M+ more.
See the full JNJ reaction history →Email me when JNJ moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to JNJ's baseline. Nothing else.
How comparable JNJ events have landed.
Across 5 other recent Johnson & Johnson press release events, the median close-day reaction was +0.62%. Each is measured the same way, from its own news timestamp.
8 more JNJ events, each measured the same way.
Recent JNJ events, each with its measured reaction8
That same day, across the market1
Same measurement, same clock, different names — each headline measured from its own news timestamp, point-in-time.
Peer tickers, measured the same way4
Every US ticker is measured the same way, from its own news timestamp. Browse all tickers →
How the numbers are made.
How was JNJ's 5-minute reaction measured?
From the news timestamp, not the trading day: News Quantified takes the last trade before this press release as the base price and measures the move five minutes of trading later — point-in-time, zero look-ahead. The same clock produced the to-close figure.
What is Johnson & Johnson's median reaction, and how does this event compare?
Johnson & Johnson's median is drawn from 2,000+ labeled events; at 30 minutes it sits at +0.06%, and +0.06% by the close. This event's move is one draw from that distribution — ordinary or outlier, the chart's median ticks show which.
Only one Johnson & Johnson headline was labeled Oct 24, 2026. How is it isolated?
It was the only Johnson & Johnson headline labeled that day, so its window has no same-day overlap — the move is measured cleanly from its own timestamp.
Does a measured reaction predict Johnson & Johnson's next reaction?
No. a measured reaction is a realized fact about Oct 24, 2026, not a forecast. Past reactions describe a distribution; they say nothing certain about any future move.
How to cite this reaction.
News Quantified. "Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer." JNJ realized price reaction, Oct 24, 2026. Retrieved from https://newsquantified.com/tickers/jnj/news/johnson-johnson-announces-erleada-apalutamide-treatment-2026-10-24
Canonical URL: https://newsquantified.com/tickers/jnj/news/johnson-johnson-announces-erleada-apalutamide-treatment-2026-10-24
Query this dataset via the API & MCP →